Nursing Elites

1. A public health nurse is developing guidelines for the management of a botulism outbreak. Which of the following information should the nurse include?

• A. High-risk individuals should receive immunoglobulin E (IgE)
• B. Implement airborne precautions for clients who have botulism
• C. Administer an aminoglycoside medication
• D. Rinse skin with soap and water following exposure to the botulism toxin

Correct answer: D

Rationale: The correct answer is D. Rinsing the skin with soap and water following exposure to the botulism toxin is crucial as it helps remove the toxin from the skin, preventing further absorption. Choices A, B, and C are incorrect. Immunoglobulin E (IgE) is not used in the management of botulism. Airborne precautions are not necessary for botulism as it is not transmitted through the air. Aminoglycoside medications are not the treatment of choice for botulism.

2. A healthcare provider is assessing a patient with dehydration. Which finding indicates the patient's condition is worsening?

• A. Dry mucous membranes.
• B. Tachycardia and low blood pressure.
• C. Bradycardia and shallow respirations.
• D. Clear lung sounds.

Correct answer: B

Rationale: Tachycardia and low blood pressure are indicative of worsening dehydration in a patient. Tachycardia is the body's compensatory mechanism to maintain cardiac output in response to decreased intravascular volume, while low blood pressure reflects inadequate perfusion due to decreased fluid levels. Bradycardia and shallow respirations are not typical findings in worsening dehydration, and clear lung sounds do not directly correlate with the severity of dehydration.

3. A client has bilateral eye patches following an injury. When the client's food tray arrives, which of the following interventions should the nurse take to promote independence in eating?

• A. Explain to the client that their tray is here and place their hands on it
• B. Ask the client if they would prefer a liquid diet
• C. Assign an assistive personnel to feed the client
• D. Describe to the client the location of the food on the tray

Correct answer: D

Rationale: Describing the location of food on the tray helps promote independence for the client with bilateral eye patches. By providing clear instructions on where the food is placed, the client can independently locate and consume their meal. Option A is incorrect as physically placing the client's hands on the tray does not encourage independence. Option B is unnecessary unless there are specific dietary restrictions indicated. Option C does not promote the client's independence and should be avoided unless absolutely necessary.

4. How should a healthcare provider manage a patient with deep vein thrombosis (DVT)?

• A. Monitoring for signs of pulmonary embolism
• B. Applying compression stockings
• C. Administering anticoagulants as prescribed
• D. Encouraging leg elevation to reduce swelling

Correct answer: A

Rationale: Corrected Rationale: Monitoring for signs of pulmonary embolism is crucial in patients with deep vein thrombosis (DVT) as it can be a life-threatening complication. While administering anticoagulants as prescribed is important for preventing clot progression, the immediate concern is detecting potential pulmonary embolism. Applying compression stockings and encouraging leg elevation are beneficial measures for managing DVT symptoms but are not as critical as monitoring for pulmonary embolism.

5. A healthcare professional in a clinic sees a client who has an acute asthma exacerbation. Which of the following medications should reduce the symptoms?

• A. Cromolyn via metered dose inhaler
• B. Budesonide via dry powder inhaler
• C. Montelukast orally
• D. Albuterol via jet nebulizer

Correct answer: D

Rationale: Albuterol via jet nebulizer is the correct choice in this scenario as it is a short-acting bronchodilator that quickly relieves bronchospasm during an asthma exacerbation. Cromolyn (Choice A) is a mast cell stabilizer used for prevention, not quick relief. Budesonide (Choice B) is an inhaled corticosteroid used for long-term control, not for acute symptom relief. Montelukast (Choice C) is a leukotriene receptor antagonist used for maintenance therapy, not for immediate symptom relief during an exacerbation.

Similar Questions